K

KeyMed Biosciences Inc
HKEX:2162

Watchlist Manager
KeyMed Biosciences Inc
HKEX:2162
Watchlist
Price: 41.4 HKD -5.26%
Market Cap: 11.4B HKD
Have any thoughts about
KeyMed Biosciences Inc?
Write Note

Intrinsic Value

KeyMed Biosciences Inc's intrinsic value estimate is unreliable because it is based only on its multiples and doesn't use a DCF valuation.

The intrinsic value of one KeyMed Biosciences Inc stock under the Base Case scenario is 39.93 HKD. Compared to the current market price of 41.4 HKD, KeyMed Biosciences Inc is Overvalued by 4%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

Intrinsic Value
39.93 HKD
Overvaluation 4%
Intrinsic Value
Price
K
Worst Case
Base Case
Best Case

Valuation Backtest
KeyMed Biosciences Inc

Backtest Intrinsic Value
Dive into the past to invest in the future

Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start backtest now and learn if your stock is truly undervalued or overvalued!

Run Backtest
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
Register to View Results
Register to View Results

To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.

Backtest Unavailable

The backtest for KeyMed Biosciences Inc cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.

Backtest In Progress...
Backtest In Progress...
How do you feel about KeyMed Biosciences Inc?
Bearish
Neutral
Bullish
Discover Undervalued Stocks
Biotechnology Industry

Fundamental Analysis

Risks & Rewards

 

 

 

 

View All Risks & Rewards
Company Quality
No Indicators Selected
Select Indicators

Select up to 3 indicators:

Insider Trading
0-3
Months
0-6
Months
0-12
Months
0-36
Months
No Periods Selected
Select Periods

Select up to 2 periods:

Notes
AI Assistant
AI Assistant
Ask me anything about KeyMed Biosciences Inc

Provide an overview of the primary business activities
of KeyMed Biosciences Inc.

What unique competitive advantages
does KeyMed Biosciences Inc hold over its rivals?

What risks and challenges
does KeyMed Biosciences Inc face in the near future?

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for KeyMed Biosciences Inc.

Provide P/S
for KeyMed Biosciences Inc.

Provide P/E
for KeyMed Biosciences Inc.

Provide P/OCF
for KeyMed Biosciences Inc.

Provide P/FCFE
for KeyMed Biosciences Inc.

Provide P/B
for KeyMed Biosciences Inc.

Provide EV/S
for KeyMed Biosciences Inc.

Provide EV/GP
for KeyMed Biosciences Inc.

Provide EV/EBITDA
for KeyMed Biosciences Inc.

Provide EV/EBIT
for KeyMed Biosciences Inc.

Provide EV/OCF
for KeyMed Biosciences Inc.

Provide EV/FCFF
for KeyMed Biosciences Inc.

Provide EV/IC
for KeyMed Biosciences Inc.

Show me price targets
for KeyMed Biosciences Inc made by professional analysts.

What are the Revenue projections
for KeyMed Biosciences Inc?

How accurate were the past Revenue estimates
for KeyMed Biosciences Inc?

What are the Net Income projections
for KeyMed Biosciences Inc?

How accurate were the past Net Income estimates
for KeyMed Biosciences Inc?

What are the EPS projections
for KeyMed Biosciences Inc?

How accurate were the past EPS estimates
for KeyMed Biosciences Inc?

What are the EBIT projections
for KeyMed Biosciences Inc?

How accurate were the past EBIT estimates
for KeyMed Biosciences Inc?

Compare the revenue forecasts
for KeyMed Biosciences Inc with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of KeyMed Biosciences Inc and its key competitors using the latest financial data.

Compare historical revenue growth rates
of KeyMed Biosciences Inc against its competitors.

Analyze the profit margins
(gross, operating, and net) of KeyMed Biosciences Inc compared to its peers.

Compare the P/E ratios
of KeyMed Biosciences Inc against its peers.

Discuss the investment returns and shareholder value creation
comparing KeyMed Biosciences Inc with its peers.

Analyze the financial leverage
of KeyMed Biosciences Inc compared to its main competitors.

Show all profitability ratios
for KeyMed Biosciences Inc.

Provide ROE
for KeyMed Biosciences Inc.

Provide ROA
for KeyMed Biosciences Inc.

Provide ROIC
for KeyMed Biosciences Inc.

Provide ROCE
for KeyMed Biosciences Inc.

Provide Gross Margin
for KeyMed Biosciences Inc.

Provide Operating Margin
for KeyMed Biosciences Inc.

Provide Net Margin
for KeyMed Biosciences Inc.

Provide FCF Margin
for KeyMed Biosciences Inc.

Show all solvency ratios
for KeyMed Biosciences Inc.

Provide D/E Ratio
for KeyMed Biosciences Inc.

Provide D/A Ratio
for KeyMed Biosciences Inc.

Provide Interest Coverage Ratio
for KeyMed Biosciences Inc.

Provide Altman Z-Score Ratio
for KeyMed Biosciences Inc.

Provide Quick Ratio
for KeyMed Biosciences Inc.

Provide Current Ratio
for KeyMed Biosciences Inc.

Provide Cash Ratio
for KeyMed Biosciences Inc.

What is the historical Revenue growth
over the last 5 years for KeyMed Biosciences Inc?

What is the historical Net Income growth
over the last 5 years for KeyMed Biosciences Inc?

What is the current Free Cash Flow
of KeyMed Biosciences Inc?

Discuss the annual earnings per share (EPS)
trend over the past five years for KeyMed Biosciences Inc.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Revenue & Expenses Breakdown
KeyMed Biosciences Inc

Balance Sheet Decomposition
KeyMed Biosciences Inc

Current Assets 2.8B
Cash & Short-Term Investments 2.6B
Receivables 12.8m
Other Current Assets 198.8m
Non-Current Assets 1B
Long-Term Investments 21.9m
PP&E 946.4m
Intangibles 2.5m
Other Non-Current Assets 46.4m
Current Liabilities 559.7m
Accounts Payable 30.1m
Other Current Liabilities 529.6m
Non-Current Liabilities 609.1m
Long-Term Debt 365m
Other Non-Current Liabilities 244.1m
Efficiency

Earnings Waterfall
KeyMed Biosciences Inc

Revenue
81.7m CNY
Cost of Revenue
-25.6m CNY
Gross Profit
56.1m CNY
Operating Expenses
-769.8m CNY
Operating Income
-713.7m CNY
Other Expenses
-29.3m CNY
Net Income
-743.1m CNY

Free Cash Flow Analysis
KeyMed Biosciences Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate
Fundamental Scores

Profitability Score
Profitability Due Diligence

KeyMed Biosciences Inc's profitability score is 26/100. The higher the profitability score, the more profitable the company is.

Positive Gross Profit
Exceptional Revenue Growth Forecast
Negative 1-Year Revenue Growth
Negative Operating Income
26/100
Profitability
Score

KeyMed Biosciences Inc's profitability score is 26/100. The higher the profitability score, the more profitable the company is.

Solvency Score
Solvency Due Diligence

KeyMed Biosciences Inc's solvency score is 73/100. The higher the solvency score, the more solvent the company is.

High Altman Z-Score
Short-Term Solvency
Negative Net Debt
Low D/E
73/100
Solvency
Score

KeyMed Biosciences Inc's solvency score is 73/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

Price Targets Summary
KeyMed Biosciences Inc

Wall Street analysts forecast KeyMed Biosciences Inc stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for KeyMed Biosciences Inc is 60.79 HKD with a low forecast of 50.5 HKD and a high forecast of 75.6 HKD.

Lowest
Price Target
50.5 HKD
22% Upside
Average
Price Target
60.79 HKD
47% Upside
Highest
Price Target
75.6 HKD
83% Upside
View Analyst Estimates
View Analyst Estimates
Want to learn more about Wall St estimates for KeyMed Biosciences Inc?

Click here to dive deeper.

Dividends

KeyMed Biosciences Inc
does not pay dividends
Shareholder Yield

Current shareholder yield for KeyMed Biosciences Inc is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Profile

KeyMed Biosciences Inc

Country

China

Industry

Biotechnology

Market Cap

11.6B HKD

Dividend Yield

0%

Description

Keymed Biosciences, Inc. is an investment holding company. The company is headquartered in Chengdu, Sichuan. The company went IPO on 2021-07-08. The firm focuses on the independent discovery and development of innovative biological therapies that address underserved medical needs in the autoimmune and oncology therapeutic areas. The firm has mastered in-house drug discovery and development technologies, including an innovative antibody discovery platform and a proprietary novel T cell engager (nTCE) bispecific antibody platform. The firm has also established a fully integrated platform covering the key functions of biopharmaceutical development. The firm's main products include CM310, CM326 and CMG901.

Contact

SICHUAN
Chengdu
18 BioTown Middle Road Building D2, Chengdu Tianfu International BioTown
www.keymedbio.com

IPO

2021-07-08

Employees

211

Officers

Executive Chairman & CEO
Dr. Bo Chen
Senior VP & Executive Director
Dr. Changyun Wang
Senior VP & Non Executive Director
Mr. Qi Chen
CFO, VP & Joint Company Secretary
Mr. Yanrong Zhang
Senior Vice President
Dr. Qian Jia
Joint Company Secretary
Ms. Pak Yu Tam A.C.I.S., A.C.S.

See Also

Discover More
What is the Intrinsic Value of one KeyMed Biosciences Inc stock?

The intrinsic value of one KeyMed Biosciences Inc stock under the Base Case scenario is 39.93 HKD.

Is KeyMed Biosciences Inc stock undervalued or overvalued?

Compared to the current market price of 41.4 HKD, KeyMed Biosciences Inc is Overvalued by 4%.

Back to Top